CPhI China 2013 Increases Customer Content Services and Expands Thanks to a Double Digit Pharma Industry Growth Rate and a Burgeoning Generics Market

AsiaNet 52934

AMSTERDAM, May 7/PRN=KYODO JBN/ --

    Co-located events P-MEC/ICSE/BioPh/InnoPack/LABWorld are helping to build

improved partnerships and drive GMP standards across the region

    CPhI announces that CPhI China [http://www.cphi-china.com ], an event

organised by UBM Live and UBM Sinoexpo, is returning to the Shanghai New

International Expo Center (25-27 June 2013, Shanghai) for the 13th consecutive

year - with an increased scale, more informative exhibition and regional

networking opportunities and a greater range of content services than it has

ever offered before. With a view to enhancing the customer experience and ROI

value, CPhI China has added mobile applications, high value conferences, a live

laboratory showcase and re-launched the show daily. Furthermore, the

2013 event has a strong focus on R&D with LABWorld, BioPharma and ICSE all

contained in one hall. China has increasingly become a focal point of the

pharmaceutical industry and is now the 3rd largest market in the world. Fuelled

by increasing healthcare demands within its own borders as well as by

international companies seeking manufacturing facilities, China's hunger for

foreign partnerships and pharmaceutical ingredients presents a great

opportunity for international and domestic suppliers and buyers.

    CPhI China is back this year as the main event for the pharmaceutical

ingredients industry in the fast growing Chinese market. We expect to welcome

2,300 exhibitors, and 30,000 visitors from more than 100 countries, CPhI China

2013 is a unique one-stop platform to meet current partners, build new

relationships, evaluate pharmaceutical products and learn about the latest

industry trends.

    Co-located events re-confirmed for the 2013 edition will be P-MEC China,

which covers machinery and equipment; ICSE China, for companies providing

outsourcing services in custom synthesis and clinical trials; BioPh China, a

dedicated platform for biopharmaceuticals; and InnoPack, focussed on bringing

global packaging solutions to the Chinese pharma companies. Additionally,

following huge demand in 2012, this year will also see a significant expansion

of co-located event, LABWorld China - which will focus on innovation and new

developments, providing a forum for increased education and networking for

businesses in the laboratory, analytical and biotech equipment sector.

    The number of exhibitors already registered has seen a tremendous upsurge

thanks to increased Chinese manufacturing opportunities and huge growth in

China's generics sector. This rapid development, coupled with the evolving

regulatory landscape is attracting both domestic and international investors to

the Chinese market.

    CPhI China 2013 brings great expectations and is a must attend event for

anyone interested in breaking into China's pharmaceuticals market and

establishing Chinese partners.

    "In 2012, the size of the Chinese pharmaceutical market reached 926.1

billion RMB, and is expected to expand at an annual rate of 12% from 2013 to

2020," announced Nik Rudge, Managing Director at UBM Live. "Today, leading

Chinese CROs and pharmaceutical companies are able to offer high quality,

cost-effective services on a global scale with growth rates forecast to far

outpace the rest of the industry. The increasing ability of Chinese companies

to meet international standards in drug quality and safety, coupled with strong

growth in the local market, makes this is a must attend event for any

pharmaceutical

company in 2013 - whether Chinese, regional or international in focus."

    Attendance to the events is free for qualified pharmaceutical professionals

at http://www.cphi-china.com

    Event information:

    CPhI China

    25-27 June 2013

    The Shanghai New International Expo Center

    http://www.cphi-china.com

    Notes for Editors

    About CPhI

    CPhI drives growth and innovation at every step of the global

pharmaceutical supply chain from drug discovery to finished dosage. Through

exhibitions, conferences and online communities, CPhI brings together more than

100,000 pharmaceutical professionals each year to network, identify business

opportunities and expand the global market. The flagship event, CPhI Worldwide

is held in Europe, with additional events in China, India, Japan, Southeast

Asia, Russia and South America co-located with ICSE for contract services, P-MEC

for equipment, InnoPack for packaging and BioPh for biopharma. CPhI provides an

online buyer & supplier directory at CPhI-Online.com and hosts a global

community with news and analysis at PharmaEvolution.com, produced by UBM Live

and partners.

    For more information visit: http://www.cphi.com

    About UBM Live

    UBM Live connects people and creates opportunities for companies across five

continents to develop new business, meet customers, launch new products,

promote their brands, and expand their market. Through premier brands such as

TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete

Show, and many others, UBM Live exhibitions, conferences, awards programs,

publications, Websites, and training and certification programs are an integral

part of the marketing plans of companies across more than 20 industry sectors.

    For media enquiries, please contact:

    Alex Heeley or Tristan Jervis

    De Facto Communications

    T: +44-207-203-6745/6740

    E: a.heeley@defacto.com  t.jervis@defacto.com

    SOURCE: UBM Live